This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Graham, S. J. Articles by Szabadi, E. Search for Related Content PubMed PubMed Citation Articles by Graham, S. J. Articles by Szabadi, E. Social Bookmarking                         What's this?

Effects of ketanserin and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man

R. W. Langley

A. M. Balboa Verduzco

Division of Psychiatry, University of Nottingham, Nottingham, UK

C. M. Bradshaw

Psychopharmacology Section, Division of Psychiatry, University of Nottingham, Room B 109, Medical School, Queen's Medical Centre, Nottingham NG7 2UH,UK

E. Szabadi

Division of Psychiatry, University of Nottingham, Nottingham, UK

Contraction of the orbicularis oculi muscle in response to a sudden loud sound (acoustic startle response) and the N1/P2 component of the auditory evoked potential are both attenuated when a brief low-intensity stimulus is presented 30–500 ms before the ‘startle-eliciting’ stimulus (prepulse inhibition). Here, we report the effects of the serotonin (5-HT)2 receptor antagonist ketanserin and the D2 dopamine receptor blocking antipsychotic drug haloperidol on these responses. Fifteen males (aged 18–35 years) participated in four sessions at 7-day intervals, in which they received ketanserin 20 mg, ketanserin 40 mg, haloperidol 3 mg and placebo, according to a balanced double-blind design. Electromyographic (EMG) responses of the orbicularis oculi muscle and N1/P2 auditory evoked potentials were recorded in a 20-min session, 3 h after ingestion of haloperidol or 1 h after ingestion of ketanserin. Subjects received 40 trials in which 1-kHz sounds were presented: (i) 40 ms, 115 dB (‘pulse alone’ trials), and (ii) 40 ms, 85 dB, followed after 120 ms by 40 ms, 115 dB (‘prepulse/pulse’ trials). Mean amplitudes of the EMG response and the N1/P2 potential were derived from the pulse-alone trials and, in each case, percentage prepulse inhibition was calculated. Serum prolactin was measured after each treatment, and autonomic (heart rate, blood pressure, salivation) and psychological (visual analogue self-ratings of mood and alertness, critical flicker fusion frequency) measures were taken before and after each treatment. Ketanserin 40 mg significantly reduced the amplitude of the EMG response and both doses of ketanserin significantly suppressed prepulse inhibition of the response; haloperidol had no effect on EMG response amplitude or prepulse inhibition. Neither drug affected N1/P2 amplitude or prepulse inhibition of this response. Ketanserin, but not haloperidol, reduced subjective alertness and critical flicker fusion frequency. Haloperidol, but not ketanserin, elevated serum prolactin level. These results confirm that prepulse inhibition of the startle response and of the N1/P2 complex have different pharmacological sensitivities. The ability of ketanserin to attenuate the startle response may reflect its sedative action, as other drugs with sedative properties have also been found to attenuate the startle response in man. The ability of ketanserin to suppress prepulse inhibition of the startle response is consistent with previous evidence for the involvement of 5-HTergic mechanisms in the regulation of prepulse inhibition in man.

Key Words: acoustic startle response • eyeblink • N1/P2 complex • auditory evoked potential • prepulse inhibition • ketanserin • haloperidol • 5-HT2 receptors • D2 receptors

Journal of Psychopharmacology, Vol. 16, No. 1, 15-22 (2002)
DOI: 10.1177/026988110201600101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. J. Graham, J. C. Scaife, R. W. Langley, C. M. Bradshaw, E. Szabadi, L. Xi, T. Crumley, N. Calder, K. Gottesdiener, and J. A. Wagner Effects of lorazepam on fear-potentiated startle responses in man J Psychopharmacol, May 1, 2005; 19(3): 249 - 258. [Abstract] [PDF]

				S. J. Graham, J. C. Scaife, A. M. B. Verduzco, R. W. Langley, C. M. Bradshaw, and E. Szabadi Effects of Quetiapine and Haloperidol on Prepulse Inhibition of the Acoustic Startle (Eyeblink) Response and the N1/P2 Auditory Evoked Response in Man J Psychopharmacol, June 1, 2004; 18(2): 173 - 180. [Abstract] [PDF]